Clinovations Welcomes New Partner Doug Cusick

January 16, 2013

Clinovations, LLC announces Doug Cusick as Partner.

Washington, DC (PRWEB) January 16, 2013

Clinovations, LLC announced today that Doug Cusick has joined the firm as Partner. In his role, Cusick will lead the continued expansion of the Payer, Life Sciences, and Technology service lines.

“Doug´s extensive knowledge and proven track record of success in the Healthcare and Life Sciences industry made him a perfect addition to the Clinovations team,” said Dr. Trenor Williams, CEO of Clinovations. “His impressive international and technical experience will work to bring together the Clinovations portfolio to ultimately provide patients with more efficient, effective, and safer care.”

Cusick brings more than 27 years of experience to the Clinovations team. Most recently, Cusick served as the vice president and general manager of the Health & Life Sciences (HLS) industries business at HP where his portfolio included Provider, Payer, and Biotechnology customers. Prior to that, Cusick worked at IBM, where he served as the industry executive for the Europe & Growth Markets in the Healthcare and Life Sciences organization and also lead global sales, distribution, marketing, and branding efforts across all IBM brands in the healthcare segment.

Cusick is active in several industry associations, including the Health Information and Management Systems Society (HIMSS), American Association of Health Plans (AAHP), American Society of Health-System Pharmacists (ASHP), and Washington State Society of Health System Pharmacists (WSSHP).

Cusick holds a PharmD degree from the University of Washington in Seattle.

About Clinovations

Clinovations is a leading healthcare consulting firm offering strategic, clinical, and health IT advisory and management consulting services with the goal of creating innovative solutions to improve the efficiency, effectiveness, and quality of healthcare for patients. More than half of our extraordinary team consists of physicians and nurses; the remainder is made up of technology leaders, business executives, management consultants, and public policy experts. We are dedicated to helping lead organizations in achieving their financial, operational, and clinical objectives.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10320785.htm

Source: prweb

comments powered by Disqus